Is Illumina Inc. (NASDAQ:ILMN) a buy in 2026?
Hold. Illumina Inc. is a wait-and-watch at today's price, not a fresh buy.
The sequencing monopoly is intact but the growth engine has stalled, and NovaSeq X adoption needs to translate into consumables pull-through before this re-rates.
Where ILMN is headed
Illumina in 2028 looks less like the hypergrowth genomics darling of 2021 and more like a mature toolmaker with a fortress installed base and a stubborn consumables flywheel. The NovaSeq X transition (started in 2023, still grinding through in 2026) is the whole ball game. Roughly 2,000 instruments are placed, but pull-through per box is still climbing the curve as customers move from validation runs to production sequencing. By late 2027, if pull-through normalises near historical levels (~$1.1M per high-throughput box), consumables revenue compounds in the high single digits without Illumina needing to sell a single new instrument. That's the bull skeleton.
Read the full Compass Direction on ILMN
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $160.03).
See the full ILMN analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Illumina Inc. (NASDAQ:ILMN) a buy in 2026?
Hold. Illumina Inc. is a wait-and-watch at today's price, not a fresh buy. The sequencing monopoly is intact but the growth engine has stalled, and NovaSeq X adoption needs to translate into consumables pull-through before this re-rates.
What is ILMN's Compass Score?
Illumina Inc. scores 46/100 on Alexandria's Compass, placing it in the "Neutral" tier. Scores blend eight factors and update weekly.
What is the price target for ILMN?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the ILMN page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.